Comparative In-Vitro Cytotoxicity Study of Homeopathic Nosodes and Allopathic Counterparts on Human Cancer Cell Lines

Abstract

Nosodes, derived from pathological tissues or disease products, represent one of the most controversial and understudied branches of homeopathic pharmacy. In contrast to conventional allopathic vaccines or chemotherapeutic agents, nosodes claim therapeutic benefits without cytotoxic effects. This study aims to assess the cytotoxic potential of Carcinosin, Tuberculinum, and Medorrhinum nosodes on MCF-7 (breast cancer), HeLa (cervical cancer), and A549 (lung cancer) human cell lines, in comparison with standard chemotherapeutic agents like Doxorubicin and Cisplatin. Using MTT assays, flow cytometry, and reactive oxygen species (ROS) assays, the study demonstrates minimal cytotoxicity of nosodes while indicating a potential immunomodulatory effect as reflected in cytokine stimulation and apoptotic marker expression. The results offer insight into the potential for integrating nosodes as adjuvant therapies in oncology, especially for palliative care patients sensitive to chemotherapy toxicity. The study recommends deeper exploration of epigenetic influence and biofield interaction facilitated by potentized nosodes.

Keywords: Homeopathic nosodes, Carcinosin, Tuberculinum, cancer cell lines, cytotoxicity, MTT assay, ROS modulation, apoptosis, complementary oncology, palliative treatment.